|
1
|
Kwon OH, Park JL, Baek SJ, Noh SM, Song
KS, Kim SY and Kim YS: Aberrant upregulation of ASCL2 by promoter
demethylation promotes the growth and resistance to 5-fluorouracil
of gastric cancer cells. Cancer Sci. 104:391–397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pisani P, Parkin DM, Bray F and Ferlay J:
Erratum: Estimates of the worldwide mortality from 25 cancers in
1990. Int J Cancer, 83, 18–29 (1999). Int J Cancer. 83:870–873.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuasa Y: Control of gut differentiation
and intestinal-type gastric carcinogenesis. Nat Rev Cancer.
3:592–600. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Massari ME and Murre C: Helix-loop-helix
proteins: Regulators of transcription in eucaryotic organisms. Mol
Cell Biol. 20:429–440. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miyamoto T, Jinno Y, Sasaki T, Ikeda Y,
Masuzaki H, Niikawa N and Ishikawa M: Genomic cloning and
localization to chromosome 11p15.5 of the human achaete-scute
homolog 2 (ASCL2). Cytogenet Cell Genet. 73:312–314. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Flier LG, van Gijn ME, Hatzis P,
Kujala P, Haegebarth A, Stange DE, Begthel H, van den Born M,
Guryev V, Oving I, et al: Transcription factor achaete scute-like 2
controls intestinal stem cell fate. Cell. 136:903–912. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jubb AM, Chalasani S, Frantz GD, Smits R,
Grabsch HI, Kavi V, Maughan NJ, Hillan KJ, Quirke P and Koeppen H:
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is
upregulated in intestinal neoplasia. Oncogene. 25:3445–3457. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu R, Yang Y, Tian Y, Bai J, Zhang X, Li
X, Peng Z, He Y, Chen L, Pan Q, et al: Ascl2 knockdown results in
tumor growth arrest by miRNA-302b-related inhibition of colon
cancer progenitor cells. PLoS One. 7:e321702012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs-the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gal H, Pandi G, Kanner AA, Ram Z,
Lithwick-Yanai G, Amariglio N, Rechavi G and Givol D: MIR-451 and
Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
Biochem Biophys Res Commun. 376:86–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee NS, Kim JS, Cho WJ, Lee MR, Steiner R,
Gompers A, Ling D, Zhang J, Strom P, Behlke M, et al: miR-302b
maintains ‘stemness’ of human embryonal carcinoma cells by
post-transcriptional regulation of Cyclin D2 expression. Biochem
Biophys Res Commun. 377:434–440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong
C, Huang Y, Hu X, Su F, Lieberman J and Song E: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsujimoto H, Ono S, Ichikura T, Matsumoto
Y, Yamamoto J and Hase K: Roles of inflammatory cytokines in the
progression of gastric cancer: Friends or foes? Gastric Cancer.
13:212–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian Y, Pan Q, Shang Y, Zhu R, Ye J, Liu
Y, Zhong X, Li S, He Y, Chen L, et al: MicroRNA-200 (miR-200)
cluster regulation by achaete scute-like 2 (Ascl2): Impact on the
epithelial-mesenchymal transition in colon cancer cells. J Biol
Chem. 289:36101–36115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Solt LA, Griffin PR and Burris TP: Ligand
regulation of retinoic acid receptor-related orphan receptors:
Implications for development of novel therapeutics. Curr Opin
Lipidol. 21:204–211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Becker-Andre M, Andre E and DeLamarter JF:
Identification of nuclear receptor mRNAs by RT-PCR amplification of
conserved zinc-finger motif sequences. Biochem Biophys Res Commun.
194:1371–1379. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schuijers J, Junker JP, Mokry M, Hatzis P,
Koo BK, Sasselli V, Van der Flier LG, Cuppen E, van Oudenaarden A
and Clevers H: Ascl2 acts as an R-spondin/Wnt-responsive switch to
control stemness in intestinal crypts. Cell Stem Cell. 16:158–170.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carlberg C, Hooft van Huijsduijnen R,
Staple JK, DeLamarter JF and Becker-André M: RZRs, a new family of
retinoid-related orphan receptors that function as both monomers
and homodimers. Mol Endocrinol. 8:757–770. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jetten AM, Kurebayashi S and Ueda E: The
ROR nuclear orphan receptor subfamily: Critical regulators of
multiple biological processes. Prog Nucleic Acid Res Mol Biol.
69:205–247. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gawlas K and Stunnenberg HG: Differential
transcription of the orphan receptor RORbeta in nuclear extracts
derived from Neuro2A and HeLa cells. Nucleic Acids Res.
29:3424–3432. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stamatopoulos B, Meuleman N, Haibe-Kains
B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P,
Bron D and Lagneaux L: microRNA-29c and microRNA-223
down-regulation has in vivo significance in chronic lymphocytic
leukemia and improves disease risk stratification. Blood.
113:5237–5245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly
MB, Wang Y, Qian Z, Jin J, Zhang Y, et al: MicroRNA expression
signatures accurately discriminate acute lymphoblastic leukemia
from acute myeloid leukemia. Proc Natl Acad Sci USA. 104:pp.
19971–19976. 2007; View Article : Google Scholar : PubMed/NCBI
|
